Dabigatran versus Warfarin in Patients with Atrial FibrillationStuart J. Connolly, Lars Wallentin, Campbell Joyner et al.|New England Journal of Medicine|2009Cited by 11.2k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationJohn W. Eikelboom, Salim Yusuf, Lars Wallentin et al.|Circulation|2011Cited by 1.1k
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Salim Yusuf et al.|The Lancet|2010Cited by 1k
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P. Piccini, Veronika Eder, Valeria Caso et al.|The Lancet|2022Cited by 310
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conferenceRenate B. Schnabel, Tatjana Potpara, Elena Andreassi Marinelli et al.|EP Europace|2022Cited by 178